SMC accepts oral therapy for relapsing multiple sclerosis
Janssen’s Ponvory accepted for use within NHS Scotland for adults RRMS patients
Read More
Author: Lucy Parsons
CN Bio inks COVID-19 research deal with iiCON
iiCON’s lead partner LSTM will independently validate CN Bio’s novel lung and lung-liver models
Read More
Sanofi invests $40m in UK gene therapy company Gyroscope Therapeutics
Funding proceeds will be used to support ongoing trials of Gyroscopes investigational gene therapy GT005
Read More
NHS staff face spring deadline for mandatory COVID vaccination
The government is expected to announce that frontline staff in England will have to be fully vaccinated against COVID-19
Read More
Positive results for GSK’s anaemia drug daprodustat
Daprodustat is an investigational oral hypoxia-inducible factor prolyl hydroxylase inhibitor in development for anaemia due to chronic kidney disease
Read More- Transgene completes randomisation in phase 2 trial of tg4050
- Bayer wins MHRA approval for Kerendia in heart failure
- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
- Kainova expands DT 7012 trial into Europe
- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
